• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[辐射与生物反应调节剂(BRMs)在恶性肿瘤治疗中的相互作用]

[Interactions of radiation and biological response modifiers (BRMs) in the treatment of malignant tumor].

作者信息

Mitsuhashi N, Takahashi M, Okazaki A, Niibe H

机构信息

Dept. of Radiology, Gunma Univ. School of Med.

出版信息

Gan No Rinsho. 1990 Oct;36(13):2272-7.

PMID:2250347
Abstract

This article reports on attempt to characterize the interactions of radiation and BRMs in the treatment of malignant tumor on the basis of our some experimental results. BRMs have a high possibility to enhance radiation effects on tumor cells with in a radiation field and bring some benefits to host tumor immune system with minimizing deleterious effects of irradiation to the immune responses. But it is very difficult to determine the rational design of administration of BRMs to induce the most effective interactions on relevant immune system and other host responses in the combination with radiotherapy. We should make it clear how radiation can be useful to potentiate the tumor antigenecity or antitumor immune responses.

摘要

本文基于我们的一些实验结果,报道了在恶性肿瘤治疗中对辐射与生物反应调节剂(BRMs)相互作用进行表征的尝试。生物反应调节剂极有可能增强辐射对辐射场内肿瘤细胞的作用,并在将辐射对免疫反应的有害影响降至最低的同时,给宿主肿瘤免疫系统带来一些益处。但是,要确定生物反应调节剂的合理给药方案,以在与放疗联合时对相关免疫系统和其他宿主反应诱导最有效的相互作用,是非常困难的。我们应该弄清楚辐射如何能够有助于增强肿瘤抗原性或抗肿瘤免疫反应。

相似文献

1
[Interactions of radiation and biological response modifiers (BRMs) in the treatment of malignant tumor].[辐射与生物反应调节剂(BRMs)在恶性肿瘤治疗中的相互作用]
Gan No Rinsho. 1990 Oct;36(13):2272-7.
2
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].干扰素和白细胞介素与放疗联合的抗肿瘤作用。第一部分:免疫学基础
Strahlenther Onkol. 2004 Apr;180(4):187-93. doi: 10.1007/s00066-004-9119-x.
3
[Clinical evaluation of biological response modifiers (BRMs) combined with radiotherapy].
Gan No Rinsho. 1988 Oct;34(13):1816-20.
4
Cancer therapy by biological response modifiers.生物反应调节剂的癌症治疗
Arzneimittelforschung. 1987 Feb;37(2A):246-50.
5
Adoptive immunotherapy of cancer: biological response modifiers and cytotoxic cell therapy.癌症的过继性免疫疗法:生物反应调节剂与细胞毒性细胞疗法。
Biotherapy. 1992;5(2):119-29. doi: 10.1007/BF02171697.
6
[Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].[瘤内给药时各种生物反应调节剂的抗肿瘤效果差异:免疫抑制酸性蛋白的诱导]
Gan To Kagaku Ryoho. 1993 Aug;20(11):1453-6.
7
Ex vivo and in vivo characterization of biological response modifiers (BRMs).生物反应调节剂(BRM)的体外和体内特性研究
Dev Biol Stand. 1992;77:143-5.
8
New antineoplastic therapies and inherent risks: monoclonal antibodies, biologic response modifiers and interleukin-2.
J Intraven Nurs. 1989 Mar-Apr;12(2):103-13.
9
Cytokines and cancer: experimental systems.细胞因子与癌症:实验系统
Curr Opin Immunol. 1991 Oct;3(5):694-8. doi: 10.1016/0952-7915(91)90098-l.
10
[Differences of antitumor effect of various BRMs by intratumoral administration].[不同生物反应调节剂瘤内注射的抗肿瘤效果差异]
Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1429-32.

引用本文的文献

1
Radioimmunodetection of lung cancer with IMACIS-1, I-131 labeled monoclonal antibodies to CEA and CA19-9. Comparison of accumulations in irradiated and non-irradiated site.使用IMACIS-1、I-131标记的抗CEA和CA19-9单克隆抗体对肺癌进行放射免疫检测。照射部位与未照射部位累积情况的比较。
Ann Nucl Med. 1993 Feb;7(1):39-44. doi: 10.1007/BF03164790.